M H O'Regan Selected Research

phosphorylethanolamine (phosphoethanolamine)

9/2003	Characterization of modes of release of amino acids in the ischemic/reperfused rat cerebral cortex.
10/2001	Inhibition of Na(+)/Ca(2+) exchange by KB-R7943, a novel selective antagonist, attenuates phosphoethanolamine and free fatty acid efflux in rat cerebral cortex during ischemia-reperfusion injury.
5/2001	Further studies on the effects of topical lactate on amino acid efflux from the ischemic rat cortex.
1/2001	Studies on the effects of lactate transport inhibition, pyruvate, glucose and glutamine on amino acid, lactate and glucose release from the ischemic rat cerebral cortex.
7/2000	The effect of intravenous insulin on accumulation of excitotoxic and other amino acids in the ischemic rat cerebral cortex.
1/2000	Topical glucose and accumulation of excitotoxic and other amino acids in ischemic cerebral cortex.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M H O'Regan Research Topics

Disease

14	Ischemia 09/2003 - 01/2000
5	Brain Ischemia (Cerebral Ischemia) 12/2002 - 06/2000
3	Reperfusion Injury 09/2002 - 09/2001
3	Stroke (Strokes) 10/2001 - 07/2000
2	Hypercapnia 07/2004 - 04/2000
2	Hyperglycemia 02/2001 - 06/2000
1	Hemorrhagic Stroke 09/2003
1	Ischemic Stroke 09/2003
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 02/2001
1	Lactic Acidosis 02/2001
1	Spinal Cord Ischemia 07/2000
1	Respiratory Acidosis 04/2000
1	Hyperemia 04/2000

Drug/Important Bio-Agent (IBA)

11	Glutamic Acid (Glutamate)FDA Link 09/2003 - 01/2000
9	Amino Acids FDA Link 09/2003 - 01/2000
7	Nonesterified Fatty Acids (NEFA)IBA 09/2003 - 11/2000
7	gamma-Aminobutyric Acid (GABA)IBA 09/2003 - 01/2000
6	phosphorylethanolamine (phosphoethanolamine)IBA 09/2003 - 01/2000
6	Aspartic Acid (Aspartate)FDA Link 09/2003 - 01/2000
6	Glucose (Dextrose)FDA LinkGeneric 05/2001 - 01/2000
5	Taurine FDA Link 09/2003 - 06/2000
4	Phospholipases (Phospholipase)IBA 09/2003 - 11/2000
3	Glycine (Aminoacetic Acid)FDA LinkGeneric 09/2003 - 06/2000
3	Lactic Acid (Lactate)FDA LinkGeneric 05/2001 - 06/2000
3	Insulin (Novolin)FDA Link 07/2000 - 05/2000
2	Neurotransmitter Agents (Neurotransmitter)IBA 09/2003 - 02/2001
2	CalciumIBA 09/2003 - 11/2000
2	SodiumIBA 10/2001 - 01/2001
2	Amiloride (Midamor)FDA LinkGeneric 09/2001 - 11/2000
2	Alanine (L-Alanine)FDA Link 05/2001 - 06/2000
2	Pyruvic Acid (Pyruvate)IBA 05/2001 - 01/2001
2	Glutamine (L-Glutamine)FDA Link 01/2001 - 06/2000
1	Adenosine (Adenocard)FDA LinkGeneric 07/2004
1	Nitric Oxide Synthase (NO Synthase)IBA 07/2004
1	EnzymesIBA 09/2003
1	Trifluoperazine (Stelazine)FDA LinkGeneric 12/2002
1	Adenosine Triphosphatases (ATPase)IBA 12/2002
1	Linoleic AcidsIBA 12/2002
1	Oleic AcidsIBA 12/2002
1	Palmitic AcidsIBA 12/2002
1	RyanodineIBA 12/2002
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 12/2002
1	ThapsigarginIBA 12/2002
1	Linoleic Acid (Linoleate)IBA 12/2002
1	BromidesIBA 09/2002
1	1- (6- ((3- methoxyestra- 1,3,5(10)- trien- 17- yl)amino)hexyl)- 1H- pyrrole- 2,5- dioneIBA 09/2002
1	Arachidonic Acid (Vitamin F)IBA 10/2001
1	Sodium-Calcium ExchangerIBA 10/2001
1	2- (2- (4- (4- nitrobenzyloxy)phenyl)ethyl)isothiourea methanesulfonateIBA 10/2001
1	Docosahexaenoic AcidsIBA 10/2001
1	SM 20220IBA 09/2001
1	Sodium-Hydrogen ExchangersIBA 09/2001
1	Arachidonic AcidsIBA 09/2001
1	alpha-cyano-4-hydroxycinnamateIBA 01/2001
1	ethylisopropylamiloride (EIPA)IBA 11/2000
1	Peptide Hydrolases (Proteases)FDA Link 11/2000
1	Streptozocin (Streptozotocin)FDA Link 07/2000
1	Serine (L-Serine)FDA Link 06/2000
1	benzyloxyaspartate (TBOA)IBA 06/2000
1	IonsIBA 06/2000
1	Neuroprotective AgentsIBA 05/2000
1	Glyburide (Glibenclamide)FDA LinkGeneric 04/2000
1	Adenosine Triphosphate (ATP)IBA 04/2000

Therapy/Procedure

1	Electrodes (Electrode) 02/2001
1	Aftercare (After-Treatment) 02/2001
1	Therapeutics 07/2000